Stress SPECT myocardial perfusion imaging in end-stage renal disease

Y Golzar, R Doukky - Current cardiovascular imaging reports, 2017 - Springer
Abstract Purpose of Review Patients with end-stage renal disease (ESRD) have an
increased risk of cardiovascular morbidity and mortality. Cardiac risk assessment, though …

Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review

A Vij, Y Golzar, R Doukky - Journal of Nuclear Cardiology, 2018 - Elsevier
Regadenoson is a selective A 2A adenosine receptor agonist that has been approved as a
vasodilator stress agent with single-photon emission-computed tomography (SPECT) …

Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR

A Abidov, V Dilsizian, R Doukky, WL Duvall… - Journal of Nuclear …, 2019 - Elsevier
Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress
is an important safety and comfort measure for patients experiencing such effects. While …

Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging

FG Hage, WA AlJaroudi - Journal of Nuclear Cardiology, 2018 - Elsevier
Abstract In 2017, the Journal of Nuclear Cardiology published many high-quality articles. In
this review, we will summarize a selection of these articles to provide a concise review of the …

Regadenoson use for stress myocardial perfusion imaging in advance chronic kidney disease and dialysis: Safe, effective, and efficient

A Gupta, NS Bajaj - Journal of Nuclear Cardiology, 2018 - Springer
The pharmacological vasodilator stress agents used for clinical stress myocardial perfusion
imaging include adenosine, dipyridamole, and regadenoson. Adenosine is a non-selective …

Effect of aminophylline administration on the diagnostic yield of vasodilator myocardial perfusion imaging

HA Daya, FG Hage - Journal of Nuclear Cardiology, 2017 - Springer
The last few decades have witnessed a steady increase in the proportion of myocardial
perfusion imaging (MPI) tests that utilize pharmacologic stress instead of exercise. 1 …

[PDF][PDF] ASNC INFORMATION STATEMENT Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement …

A Abidov, V Dilsizian, R Doukky, WL Duvall, C Dyke… - J Nucl Cardiol, 2019 - asnc.org
Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress
is an important safety and comfort measure for patients experiencing such effects. While …

Pharmacologic Stress Testing

DW Nelson, RC Hendel - … of Nuclear Cardiology: Cardiac SPECT and …, 2024 - Springer
For many patients, exercise stress testing is the preferable mode of physiologic stress
testing, as it offers insight into functional capacity and assessment of symptoms. However, in …